Sharp Rise in Deaths Linked to Novel Benzodiazepines Raises Public Health Concerns
Nikhil Prasad Fact checked by:Thailand Medical News Team Mar 11, 2026 2 hours, 6 minutes ago
Medical News: A new study has revealed a worrying increase in deaths linked to a class of powerful sedative drugs known as novel benzodiazepines (NBZDs). These substances are often designed to imitate well-known prescription medications such as Valium and Xanax but are frequently produced illegally and can be significantly more potent.
Researchers warn that powerful illicit benzodiazepines are driving a growing number of overdose deaths
Researchers have found that fatalities involving these drugs have risen dramatically over the past decade, particularly since 2020. Experts warn that the growing presence of these compounds in illicit drug markets represents an emerging public health threat.
The study was conducted by scientists from the National Drug and Alcohol Research Centre at the University of New South Wales (UNSW Sydney), Australia, who analyzed national data on poisoning deaths involving novel benzodiazepines.
Understanding Novel Benzodiazepines
Traditional benzodiazepines are widely prescribed medications used to treat conditions such as anxiety, insomnia, muscle spasms, and seizures. They work by calming the central nervous system and slowing brain activity.
Novel benzodiazepines are chemically modified versions of these medications. Many are produced in unregulated laboratories and sold through illicit markets or online platforms. While they may appear similar to legitimate pharmaceutical drugs, their chemical structure and potency can vary greatly.
In many cases, individuals may unknowingly consume these substances after purchasing counterfeit pills that resemble prescription medications. Because the strength and dosage of NBZDs can be unpredictable, their effects can be far more dangerous than expected.
Study Reveals Dramatic Increase in Fatalities
To better understand the scale of the problem, researchers reviewed records from Australia’s National Coronial Information System covering poisoning deaths between 2000 and 2025.
The analysis identified 258 confirmed deaths involving novel benzodiazepines, with the first recorded case occurring in 2013.
The most striking finding was the dramatic rise in deaths during recent years. Between 2013 and 2019, only 33 deaths were recorded. However, from 2020 to 2025, the number surged to 225 deaths, accounting for almost 87 percent of all fatalities identified in the study.
Lead researcher Emeritus Professor Shane Darke from the National Drug and Alcohol Research Centre, UNSW Sydney said the rapid increase reflects the growing availability and use of these drugs.
He emphasized that the risk of fatal overdose is particularly high when NBZDs are used together with other substances that depress breathing.
Most Frequently Detected Compounds
The research team detected 15 different types of novel benzodiazepines across the cases examined. Some of these compounds have only appeared in drug markets in recent years.
The most commonly ident
ified substances included:
-Etizolam, detected in approximately 49 percent of cases
-Bromazolam, present in about 38 percent
-Flualprazolam, found in roughly 12 percent
-Clonazolam and its metabolite 8-aminoclonazolam, detected in about 11 percent
Researchers noted that several of these compounds were first identified in toxicology reports during the 2020s, indicating how quickly the illicit drug landscape is evolving.
Dangerous Drug Combinations Common
Another major finding was that NBZDs were rarely the only substances present in fatal cases.
In all but one case, toxicology tests revealed the presence of other drugs in addition to the novel benzodiazepines. The most common accompanying substances were opioids, such as heroin, and prescription sedatives.
These combinations are especially dangerous because both opioids and benzodiazepines suppress breathing. When taken together, the risk of respiratory failure increases dramatically.
Stimulant drugs such as methamphetamine and cocaine were also detected in many cases. Mixing stimulants with depressants can place significant stress on the heart and increase the risk of dangerous cardiac rhythm disturbances.
Changing Risk Profiles in Recent Years
The study also revealed several changes in the characteristics of victims over time.
The average age of individuals who died from NBZD-related poisoning was 31.9 years, and the majority were male.
However, cases occurring in the 2020s were significantly more likely to involve people with a history of injecting drug use and mental health conditions. This suggests that the drugs are increasingly affecting populations already at elevated risk of substance misuse and overdose.
Additionally, recent cases were more than four times more likely to involve multiple novel benzodiazepines detected in toxicology results, further increasing the danger of fatal toxicity.
Overdoses Often Occur Around Others
A particularly concerning observation was that in many fatal cases, other people were nearby at the time of overdose.
Researchers found that in two-thirds of the incidents, someone else was present in the immediate vicinity. However, assistance was provided in only about half of those situations.
Experts believe that many bystanders may not recognize the warning signs of benzodiazepine overdose. Symptoms can include extremely slow or irregular breathing, loud snoring sounds, vomiting, or an inability to wake the person.
Earlier recognition and medical intervention might prevent some of these deaths.
Increasing Drug Alerts and Emergency Cases
The findings are consistent with broader trends observed by health authorities. Dr. Jack Freestone, a postdoctoral research fellow at the National Centre for Clinical Research on Emerging Drugs at UNSW Sydney, noted that 23 public drug alerts involving novel benzodiazepines were issued between 2020 and July 2025, with nearly half occurring in 2025 alone.
He also highlighted that NBZDs have become the most frequently detected category of novel psychoactive substances in Australian emergency department admissions.
To better understand how people obtain and use these substances, researchers have launched the Navigating Novel Benzos Study, which will investigate user experiences and harm-reduction strategies.
Conclusion
The study highlights a rapidly emerging drug safety crisis driven by the increasing availability of novel benzodiazepines in illicit markets. These compounds often mimic legitimate medications but can be significantly stronger and far less predictable in their effects. When combined with opioids, other sedatives, or stimulants, the risk of respiratory failure or fatal cardiac complications increases dramatically. Experts warn that many users may unknowingly consume these substances through counterfeit pills, making the threat even more serious. Improving public awareness, expanding toxicology screening in hospitals, and strengthening harm-reduction strategies will be critical to reducing deaths associated with these powerful synthetic sedatives.
This
Medical News report underscores the urgent need for monitoring and public health interventions as NBZDs continue to spread in drug markets worldwide.
The study findings were published in the peer reviewed journal: Drug and Alcohol Dependence and also in Drug and Alcohol Review.
https://www.sciencedirect.com/science/article/pii/S0376871626000669
https://onlinelibrary.wiley.com/doi/10.1111/dar.70086
For the latest on drugs and medications, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/med-news
Share
Tweet
Share
